Pharmaceutics (Apr 2022)

Amphiphilic Poly-<i>N</i>-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study

  • Andrey Kuskov,
  • Dragana Nikitovic,
  • Aikaterini Berdiaki,
  • Mikhail Shtilman,
  • Aristidis Tsatsakis

DOI
https://doi.org/10.3390/pharmaceutics14050925
Journal volume & issue
Vol. 14, no. 5
p. 925

Abstract

Read online

Nanoparticles are increasingly utilized as drug delivery agents. Previously, we have developed a drug delivery system based on amphiphilic derivatives of poly-N-vinylpyrrolidone (PVP-OD4000) with excellent biocompatibility. In the current study, we assessed the pharmacokinetics, anti-inflammatory profile, and ulcerogenic potential of indomethacin (IMC)-loaded PVP-OD4000 nanoparticles compared to the free drug. Wistar male rats were utilized for a pharmacokinetics study and an anti-inflammatory study. Loaded IMC exhibited a slower elimination rate (p p p p p p < 0.05). The obtained results suggest that IMC loaded to PVP nanoparticles exhibit superior anti-inflammatory activity in vivo and a safe gastrointestinal profile and pose a therapeutic alternative for the currently available NSAIDs’ administration.

Keywords